AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Saluda Medical Inc

0.455

-0.010-2.15%

Volume:261.21K

Turnover:119.64K

Market Cap:114.67M

PE:-0.22

High:0.475

Open:0.475

Low:0.450

Close:0.465

52wk High:1.900

52wk Low:0.360

Shares:252.02M

Float Shares:252.02M

Volume Ratio:0.23

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.062

EPS(LYR):-2.062

ROE:-127.42%

ROA:-56.96%

PB:1.51

PE(LYR):-0.22

Loading ...

Overview Company News Filings

Saluda Medical Sees FY27 Revenue Growth Between 25% and 35% Versus FY26

Saluda Medical Sees FY27 Adjusted Ebitda Loss Between Us$101 Mln and US$95 Mln

THOMSON REUTERS

Saluda Medical Sees FY27 Gross Margin 50% to 52%

THOMSON REUTERS

Saluda Medical - no Dividends Paid or Declared for FY26

THOMSON REUTERS

Saluda Medical - FY26 Revenue from Ordinary Activities $90.2 Mln

THOMSON REUTERS

Saluda Medical Inc-Preliminary Final Report

THOMSON REUTERS

Saluda Medical - FY26 Full-Year Revenue Us$90.2 Mln

THOMSON REUTERS

Saluda Medical Says First Procedures in US Performed with Surgical Paddle Leads, Shares Jump 3%

MT Newswires Live

Saluda Medical Receives U.S. FDA Approval for New Cap24™ Surgical Paddle Lead

Saluda Medical Fully Draws $25 Million From Second Tranche of Perceptive Credit Facility; Shares Gain 3%

MT Newswires Live

Saluda Medical - to Begin Phased U.S. Launch of Cap24 Paddle Lead in H2 2026

THOMSON REUTERS

Australia's Saluda Medical Rises as FDA Approves Pain-treatment Device for US Market

Saluda Medical's Surgical Paddle Lead Approved by FDA, Shares Soar 18%

MT Newswires Live

Saluda Medical Inc - Sld Receives FDA Approval for Cap24 Surgical Paddle Lead

THOMSON REUTERS

Saluda Medical Unit Receives ASIC Relief From Standalone Financial Reporting Requirements, Shares Up 3%

MT Newswires Live

Saluda Medical Inc-Asic Approval of Financial Reporting Relief for Subsidiary

THOMSON REUTERS

BUZZ-Australia's Saluda Medical climbs on strong revenue growth, forecast hike

Saluda Medical Inc - Q3 FY26 Global Revenue Rises 34% to $23.8 Mln

THOMSON REUTERS

6 ASX All Ords shares at 52-week lows: Experts say buy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/SLD.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SLD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SLD.AU\",,,,,undefined,":{"symbol":"SLD.AU","market":"AU","secType":"STK","nameCN":"Saluda Medical Inc","latestPrice":0.455,"timestamp":1788243120000,"preClose":0.465,"halted":0,"volume":261214,"delay":0,"changeRate":-0.02150537634408604,"nameEN":"Saluda Medical Inc","floatShares":252023810,"shares":252023810,"eps":-2.0621289597968566,"marketStatus":"Closed","change":-0.01,"latestTime":"09-01 16:12:00 AEST","open":0.475,"high":0.475,"low":0.45,"amount":119638,"amplitude":0.053763,"askPrice":0.465,"askSize":4499,"bidPrice":0.45,"bidSize":4207,"shortable":3,"etf":0,"ttmEps":-2.0621289597968566,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":5,"adr":0,"listingDate":1764766800000,"exchange":"ASX","adjPreClose":0.465,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":0.234505,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"SLD.AU","preClose":0.465,"auctionPrice":0.455,"auctionVolume":1000,"auctionTime":1788242997009,"referencePrice":0.455,"referenceTime":1788243690583,"auction":3,"marketStatus":"盘后竞价","timestamp":1788242997009}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SLD.AU\",,,,,undefined,":{"symbol":"SLD.AU","floatShares":252023810,"roa":"-56.96%","roe":"-127.42%","lyrEps":-2.062129,"volumeRatio":0.234505,"shares":252023810,"dividePrice":0,"high":0.475,"amplitude":0.053763,"preClose":0.465,"low":0.45,"week52Low":0.36,"pbRate":"1.51","psRate":"0.91","week52High":1.9,"institutionHeld":0,"latestPrice":0.455,"committee":-0.03354,"eps":-2.0621289597968566,"divideRate":0,"volume":261214,"delay":0,"ttmEps":-2.0621289597968566,"open":0.475,"prevYearClose":1.425,"prevWeekClose":0.48,"prevMonthClose":0.465,"prevQuarterClose":0.46,"fiveDayClose":0.615,"twentyDayClose":0.58,"sixtyDayClose":0.425},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLD.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"SLD.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787875200000,"name":null,"time":"","dateTimestamp":1787839200000,"actualEps":null},{"date":"2026-07-30","symbol":"SLD.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785369600000,"name":null,"time":"Pre-MKt","dateTimestamp":1785333600000,"actualEps":null},{"market":"AU","date":"2026-05-01","symbol":"SLD.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1777557600000,"reportTimeType":"","actualEps":null},{"date":"2026-02-26","symbol":"SLD.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SLD.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662803774","title":"Saluda Medical Sees FY27 Revenue Growth Between 25% and 35% Versus FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2662803774","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662803774?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:39","pubTimestamp":1787881148,"startTime":"0","endTime":"0","summary":"BRIEF-Saluda Medical Sees FY27 Revenue Growth Between 25% And 35% Versus FY26Aug 28 -Saluda Medical IncSLD.AX:SEES FY27 REVENUE GROWTH BETWEEN 25% AND 35% VERSUS FY26SEES FY27 ADJUSTED EBITDA LOSS BETWEEN US$101 MILLION AND US$95 MILLIONSEES FY27 GROSS MARGIN 50% TO 52%Further company coverage:SLD.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44O1IW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039369","title":"Saluda Medical Sees FY27 Adjusted Ebitda Loss Between Us$101 Mln and US$95 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039369?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:25","pubTimestamp":1787869554,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1IW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039364","title":"Saluda Medical Sees FY27 Gross Margin 50% to 52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039364?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:25","pubTimestamp":1787869554,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1IW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662398680","title":"Saluda Medical - no Dividends Paid or Declared for FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2662398680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662398680?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:21","pubTimestamp":1787869293,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE75PMX7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","SLD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039834","title":"Saluda Medical - FY26 Revenue from Ordinary Activities $90.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039834?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:21","pubTimestamp":1787869293,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE75PMX7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036013","title":"Saluda Medical Inc-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036013?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:21","pubTimestamp":1787869293,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE75PMX7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655363608","title":"Saluda Medical - FY26 Full-Year Revenue Us$90.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2655363608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655363608?lang=en_us&edition=fundamental","pubTime":"2026-07-29 06:32","pubTimestamp":1785277927,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U187:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651497664","title":"Saluda Medical Says First Procedures in US Performed with Surgical Paddle Leads, Shares Jump 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651497664","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651497664?lang=en_us&edition=fundamental","pubTime":"2026-07-16 09:53","pubTimestamp":1784166787,"startTime":"0","endTime":"0","summary":"Saluda Medical  said the first procedures in the US using the Evoke CAP24 surgical paddle lead were performed on Friday, July 10, and Tuesday, July 14, according to a Thursday Australian bourse filing.Its Evoke system is designed to treat chronic neuropathic pain by providing spinal cord stimulation  therapy that senses and measures neural activation to optimize therapy.Its shares jumped 3% in recent trading on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLD.AU","BK7007","SCS","BK4143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649641313","title":"Saluda Medical Receives U.S. FDA Approval for New Cap24™ Surgical Paddle Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2649641313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649641313?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:24","pubTimestamp":1783322693,"startTime":"0","endTime":"0","summary":"June 30 (Reuters) - Saluda Medical Inc::*SALUDA MEDICAL RECEIVES U.S. FDA APPROVAL FOR NEW CAP24 SURGICAL PADDLE LEAD*SALUDA MEDICAL - TO BEGIN PHASED U.S. LAUNCH OF CAP24 PADDLE LEAD IN H2 2026((Reut","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nRSDbwBc0N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","SLD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648994905","title":"Saluda Medical Fully Draws $25 Million From Second Tranche of Perceptive Credit Facility; Shares Gain 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648994905","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648994905?lang=en_us&edition=fundamental","pubTime":"2026-07-01 10:28","pubTimestamp":1782872924,"startTime":"0","endTime":"0","summary":"Saluda Medical  drew the full $25 million from the second tranche of its credit facility with Perceptive Credit Holdings IV, according to a Wednesday filing with the Australian bourse.In connection with the drawdown, Saluda issued a warrant to Perceptive to purchase 88,000 shares of its common stock at an exercise price of $17 each.The company will use the second-tranche proceeds for general commercial and operating purposes. It said a third tranche of $25 million is available through the end of the year, subject to certain conditions.Saluda Medical shares gained 3% in recent Wednesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","SLD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647559215","title":"Saluda Medical - to Begin Phased U.S. Launch of Cap24 Paddle Lead in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647559215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647559215?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:15","pubTimestamp":1782825300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA1ZVBHB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647862655","title":"Australia's Saluda Medical Rises as FDA Approves Pain-treatment Device for US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2647862655","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647862655?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:19","pubTimestamp":1782785968,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Saluda Medical rises as FDA approves pain-treatment device for US market** Shares of Australia's Saluda MedicalSLD.AXrise as much as 24.4% to A$0.510, hitting their highest level since May 15** Stock on track for its best day since June 2, if gains hold** The medical device firm says the U.S. Food and Drug Administration  has approved its CAP24 paddle lead** Adds that approval allows the product to be marketed and sold in the U.S.** Paddle lead is a medical device used in Spinal Cord Stimulation to treat chronic back, arm, or leg pain** Stock down over 65% this year, including the day's move","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nL4N43206F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","SLD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647358564","title":"Saluda Medical's Surgical Paddle Lead Approved by FDA, Shares Soar 18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647358564","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647358564?lang=en_us&edition=fundamental","pubTime":"2026-06-30 09:23","pubTimestamp":1782782618,"startTime":"0","endTime":"0","summary":"Saluda Medical  said the US Food and Drug Administration  approved its CAP24 surgical paddle lead, an alternative to percutaneous leads, allowing them to be marketed and sold in the US for spinal cord stimulation, according to a Thursday Australian bourse filing.The firm plans a phased US launch beginning in the second half of the year, with a broader commercial rollout starting later in the year.Its shares soared 18% in recent trading on Tuesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","DBB","SLD.AU","BK7007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647958832","title":"Saluda Medical Inc - Sld Receives FDA Approval for Cap24 Surgical Paddle Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2647958832","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647958832?lang=en_us&edition=fundamental","pubTime":"2026-06-30 07:29","pubTimestamp":1782775793,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43116B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","SLD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635777196","title":"Saluda Medical Unit Receives ASIC Relief From Standalone Financial Reporting Requirements, Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635777196","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635777196?lang=en_us&edition=fundamental","pubTime":"2026-05-15 13:57","pubTimestamp":1778824671,"startTime":"0","endTime":"0","summary":"Saluda Medical  said that the Australian Securities and Investments Commission  granted relief to its Australian unit, Saluda Medical Pty Ltd, from certain obligations, including the requirement to prepare standalone financial reports, have them audited, and report to members separately, according to a Friday Australian bourse filing.The company said the relief applies from the financial year ended June 30, and each subsequent financial year, with Saluda already preparing consolidated financial statements that include the Australian subsidiary, avoiding the need for separate engagement of Australian accountants and an external auditor.The relief also reduces the risk of shareholders and creditors being misled by separate financial reports, while creditors of the Australian subsidiary will benefit from being party to a deed of cross guarantee , it added.The company's shares rose 3% in recent Friday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1720051108.HKD","LU1854104046.USD","LU1861220033.SGD","LU1978683503.SGD","LU1861215975.USD","BK4605","LU1861214812.USD","ASIC","BK4141","LU2360107325.USD","BK4512","LU0348723411.USD","IE00BD6J9T35.USD","BK7007","LU0124384867.USD","LU2357305700.SGD","XAO.AU","BK4585","XKO.AU","LU2298322129.HKD","LU1861219969.SGD","IE00BFMHRM44.USD","XJO.AU","BK4107","LU1548497426.USD","ON","BK4588","LU1720051017.SGD","LU0724618433.USD","SLD.AU","IE00BZ199S13.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635720646","title":"Saluda Medical Inc-Asic Approval of Financial Reporting Relief for Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635720646","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635720646?lang=en_us&edition=fundamental","pubTime":"2026-05-15 08:34","pubTimestamp":1778805242,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUEBKNVMW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631675503","title":"BUZZ-Australia's Saluda Medical climbs on strong revenue growth, forecast hike","url":"https://stock-news.laohu8.com/highlight/detail?id=2631675503","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631675503?lang=en_us&edition=fundamental","pubTime":"2026-04-30 12:24","pubTimestamp":1777523062,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Saluda Medical climbs on strong revenue growth, forecast hike** Saluda Medical SLD.AX rise as much as 17% to A$0.690, their biggest gain since February 26**  Medtech firm Q3 global re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL6N41D0AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","SLD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631527723","title":"Saluda Medical Inc - Q3 FY26 Global Revenue Rises 34% to $23.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631527723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631527723?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:18","pubTimestamp":1777501089,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C1R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","SLD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620386274","title":"6 ASX All Ords shares at 52-week lows: Experts say buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2620386274","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620386274?lang=en_us&edition=fundamental","pubTime":"2026-03-20 05:30","pubTimestamp":1773955800,"startTime":"0","endTime":"0","summary":"S&P/ASX All Ords Index(ASX: XAO) shares finished 1.77% lower yesterday as the Iran war and higher oil prices worried investors.  More than 400 companies in the ASX All Ords fell yesterday, with some h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/20/6-asx-all-ords-shares-at-52-week-lows-experts-say-buy/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/20/6-asx-all-ords-shares-at-52-week-lows-experts-say-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7124","CWY.AU","JIN.AU","SLD.AU","BK7078","BK7047","OCL.AU","SHL.AU","BK7007","BK7016","GDG.AU","XAO.AU","BK7089"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}